Tuberculosis care and treatment falls short, but government moves to make improvements
Dr Shenglan Tang discusses findings from a large implementation research project examining tuberculosis care and medication use in China from 2009-2015.
Dr Shenglan Tang
Dr. Shenglan Tang is Professor of Medicine and Global Health at Duke Global Health Institute and Associate Director of DGHI for China Initiatives. He has more than 20 years’ experience undertaking research on health systems reform, disease control and maternal and child health in China and other countries.
Latest posts by Dr Shenglan Tang (see all)